Theravance Biopharma Inc (TBPH) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $17.03 (—)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 4, 2026 | Mayank Mamtani | B.Riley Financial | $14.00 | -17.8% |
| Nov 13, 2024 | David Risinger | Leerink Partners | $10.00 | -41.3% |
| Aug 6, 2024 | Douglas Tsao | H.C. Wainwright | $15.00 | -11.9% |
| Apr 12, 2024 | Julian Harrison | BTIG | $21.00 | +23.3% |
Top Analysts Covering TBPH
TBPH vs Sector & Market
| Metric | TBPH | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.25 | 2.41 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | -0.2% | +153002.0% | +21.5% |
| P/E Ratio | 7.73 | 3.46 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $50M | $56M | $66M | 3 |
| 2027-03-31 | $53M | $58M | $69M | 3 |
| 2027-06-30 | $55M | $61M | $73M | 2 |
| 2027-09-30 | $58M | $64M | $76M | 2 |
| 2027-12-31 | $61M | $67M | $80M | 3 |
| 2028-12-31 | $78M | $93M | $112M | 5 |
| 2029-12-31 | $82M | $97M | $117M | 2 |
| 2030-12-31 | $86M | $103M | $123M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.46 | $1.67 | $2.08 | 1 |
| 2027-03-31 | $0.37 | $0.42 | $0.53 | 1 |
| 2027-06-30 | $0.58 | $0.66 | $0.83 | 1 |
| 2027-09-30 | $0.36 | $0.41 | $0.50 | 1 |
| 2027-12-31 | $0.97 | $1.11 | $1.38 | 1 |
| 2028-12-31 | $0.09 | $0.84 | $1.51 | 5 |
| 2029-12-31 | $0.75 | $0.95 | $1.19 | 1 |
| 2030-12-31 | $0.90 | $1.15 | $1.44 | 1 |
Frequently Asked Questions
What is the analyst consensus for TBPH?
The consensus among 3 analysts covering Theravance Biopharma Inc (TBPH) is Hold with an average price target of $17.00.
What is the highest price target for TBPH?
The highest price target for TBPH is $21.00, set by Julian Harrison at BTIG on 2024-04-12.
What is the lowest price target for TBPH?
The lowest price target for TBPH is $10.00, set by David Risinger at Leerink Partners on 2024-11-13.
How many analysts cover TBPH?
3 analysts have issued ratings for Theravance Biopharma Inc in the past 12 months.
Is TBPH a buy or sell right now?
Based on 3 analyst ratings, TBPH has a consensus rating of Hold (3.00/5) with a -0.2% upside to the consensus target of $17.00.
What are the earnings estimates for TBPH?
Analysts estimate TBPH will report EPS of $1.67 for the period ending 2026-12-31, with revenue estimated at $56M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.